Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Coates

Showing results (371-380 of 455) with videos related to

Pageof 46
Sort By:
Breast Cancer Research and Treatment|October 28, 2008
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93Olivia Pagani, Shari Gelber, Edda Simoncini, et al.
Molecular Biology Reports|May 25, 2010
Geographic distribution of phylogenetically-distinct legume pod borer, Maruca vitrata (Lepidoptera: Pyraloidea: Crambidae)Venu M Margam, Brad S Coates, Malick N Ba, et al.
Chemical Communications (Cambridge, England)|October 7, 2022
Formation of new crystalline qtz-[Zn(mIm)2] polymorph from amorphous ZIF-8Michael F Thorne, Celia Castillo-Blas, Lauren N McHugh, et al.
Breast Cancer Research and Treatment|November 7, 2020
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trialManuela Rabaglio, Zhuoxin Sun, Rudolf Maibach, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2017
Discovery of novel benzothienoazepine derivatives as potent inhibitors of respiratory syncytial virusEuan A F Fordyce, Daniel W Brookes, Claire Lise-Ciana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 studyMarco Colleoni, Anita Giobbie-Hurder, Meredith M Regan, et al.
British Journal of Cancer|November 29, 2007
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancerJ Bernhard, D Zahrieh, J J Zhang, et al.
JCO Precision Oncology|January 24, 2025
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical TrialsStephen J Luen, Lauren C Brown, Courtney T van Geelen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IXS Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancerP Karlsson, Z Sun, D Braun, et al.
Pageof 46

Showing results (371-380 of 455) with videos related to

Sort By:
Pageof 46
Breast Cancer Research and Treatment|October 28, 2008
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93Olivia Pagani, Shari Gelber, Edda Simoncini, et al.
Molecular Biology Reports|May 25, 2010
Geographic distribution of phylogenetically-distinct legume pod borer, Maruca vitrata (Lepidoptera: Pyraloidea: Crambidae)Venu M Margam, Brad S Coates, Malick N Ba, et al.
Chemical Communications (Cambridge, England)|October 7, 2022
Formation of new crystalline qtz-[Zn(mIm)2] polymorph from amorphous ZIF-8Michael F Thorne, Celia Castillo-Blas, Lauren N McHugh, et al.
Breast Cancer Research and Treatment|November 7, 2020
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trialManuela Rabaglio, Zhuoxin Sun, Rudolf Maibach, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2017
Discovery of novel benzothienoazepine derivatives as potent inhibitors of respiratory syncytial virusEuan A F Fordyce, Daniel W Brookes, Claire Lise-Ciana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 studyMarco Colleoni, Anita Giobbie-Hurder, Meredith M Regan, et al.
British Journal of Cancer|November 29, 2007
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancerJ Bernhard, D Zahrieh, J J Zhang, et al.
JCO Precision Oncology|January 24, 2025
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical TrialsStephen J Luen, Lauren C Brown, Courtney T van Geelen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IXS Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancerP Karlsson, Z Sun, D Braun, et al.
Pageof 46